Speaker illustration

Miss Olga Rusiecka

University of Geneva, Geneva (Switzerland)

Pannexin1 as a new target for prevention of cardiac ischemia/reperfusion injury

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Ischaemia, Infarction, Cardioprotection

Session: Semmelweis University Moderated Poster Award session

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb